VCYT: Veracyte Inc Company Profile & Statistics

About

Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also developing Afirma Malignant GEC test. It serves endocrinologists, radiologists, and head and neck specialists. Veracyte, Inc. is headquartered in South San Francisco, California.

Info & Links

CEO

Marc Stapley

Headquarters

6000 SHORELINE COURT, SUITE 300
SOUTH SAN FRANCISCO, CA 94080, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

815

Veracyte Inc Statistics

Valuation Measures

Market Capitalization²

3.19B

Enterprise Value

2.91B

Enterprise Value/EBITDA(ttm)

1.39M

Price to Earnings Ratio(ttm)

95.09

Price to Sales(ttm)

7.45

Price to Book(mrq)

2.67

Price to Cash(ytd)

440.57

Profitability

Gross Margin(ttm)

70.33%

Operating Margin(ttm)

7.93%

Profit Margin(ttm)

-3.16%

Return on Equity(ttm)

3.02%

Return on Invested Capital(ttm)

-1.08%

Return on Assets(ttm)

2.80%

Income Statement

Revenue(ttm)

425.33M

Revenue Per Share(ttm)

5.49

Gross Profit(ttm)

298.85M

EBITDA(ttm)³

2.10K

Net Income Available to Common(ttm)

-9.27M

Diluted EPS(ttm)

-0.15

Share Statistics

Beta (5Y Monthly)

1.69

52-Week Change

57.73%

S&P 500 52-Week Change

26.50%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

77.50M

Dividend Yield

0.00%

Float⁴

76.49M

% Held by Insiders

1.30%

% Held by Institutions

Balance Sheet

Total Cash(mrq)

274.08M

Total Cash Per Share(mrq)

3.54

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

5.08%

Quick Ratio(mrq)

4.79%

Book Value Per Share(mrq)

15.18

Cash Flow

Operating Cash Flow Per Share(ytd)

0.64

Free Cash Flow(ytd)

43.43M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

VCYT

Veracyte Inc

Veracyte Inc Profile